Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

H-1 antihistamines may help with various skin conditions, but more research is needed to confirm their effectiveness.

Experts say proper treatment and sensitivity are important for women's facial skin issues like acne and unwanted hair.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Early treatment of PCOS in teens is crucial to prevent long-term health issues like diabetes and heart disease.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

PRP therapy may help with ovarian issues and fertility, but more research is needed.

Early diagnosis and treatment of endocrine disorders like HAIR-AN syndrome can improve outcomes in adolescents.

PCOS is best managed with a personalized mix of lifestyle changes, medication, and herbal remedies.

PCOS causes hormonal issues and infertility, with treatment options including medication and lifestyle changes.

Hirsutism in teens is often due to polycystic ovarian syndrome and needs careful assessment and support.

Ayurvedic treatment helped a woman with PCOS become pregnant and have a healthy baby.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Insulin resistance is linked to PCOS and can lead to other health issues, but treatments like metformin can help manage symptoms.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.